BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
271 results:

  • 1. Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via Akt/mTOR/MAPK pathways in hepatocellular carcinoma cells.
    Abusaliya A; Bhosale PB; Kim HH; Park MY; Jeong SH; Lee S; Kim GS
    Biomed Pharmacother; 2024 May; 174():116483. PubMed ID: 38552440
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tyrosine phosphatase
    Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
    Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exosomal IGFBP2 derived from highly metastatic promotes hepatocellular carcinoma metastasis by inducing epithelial mesenchymal transition.
    Zheng Y; Li W; Huang Y; Cheng H
    Gene; 2024 Jun; 913():148374. PubMed ID: 38490505
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrative single-cell transcriptomic analyses reveal the cellular ontological and functional heterogeneities of primary and metastatic liver tumors.
    Gui M; Huang S; Li S; Chen Y; Cheng F; Liu Y; Wang JA; Wang Y; Guo R; Lu Y; Cao P; Zhou G
    J Transl Med; 2024 Feb; 22(1):206. PubMed ID: 38414027
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. l-Methionine potentiates anticancer activity of Sorafenib by epigenetically altering DUSP3/erk pathway in hepatocellular carcinoma.
    Pal S; Kabeer SW; Sharma S; Tikoo K
    J Biochem Mol Toxicol; 2024 Mar; 38(3):e23663. PubMed ID: 38367245
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Homeobox Protein BarH-like 1 Promotes Gastric cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178.
    Gu Y; Chen G; Ning X
    Dig Dis Sci; 2024 Apr; 69(4):1182-1199. PubMed ID: 38358459
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PP4R1 promotes glycolysis and gallbladder cancer progression through facilitating erk1/2 mediated PKM2 nuclear translocation.
    He Z; Zhong Y; Lv T; Wang J; Jin Y; Li F; Hu H
    Cancer Lett; 2024 Apr; 586():216677. PubMed ID: 38301910
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
    Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
    Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A highly oxidized germacranolide from elephantopus tomentosus inhibits the growth of hepatocellular carcinoma cells by targeting EGFR in vitro and in vivo.
    Li Q; Niu JQ; Jia JH; Xu W; Bai M; Yao GD; Song SJ
    Bioorg Chem; 2024 Feb; 143():107007. PubMed ID: 38039928
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas.
    Sánchez-Tilló E; Pedrosa L; Vila I; Chen Y; Győrffy B; Sánchez-Moral L; Siles L; Lozano JJ; Esteve-Codina A; Darling DS; Cuatrecasas M; Castells A; Maurel J; Postigo A
    JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870961
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. TuBG1 promotes hepatocellular carcinoma via ATR/P53-apoptosis and cycling pathways.
    Zhang Y; Wang ZZ; Han AQ; Yang MY; Zhu LX; Pan FM; Wang Y
    Hepatobiliary Pancreat Dis Int; 2024 Apr; 23(2):195-209. PubMed ID: 37806848
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells.
    Kim ES; Kim S; Moon A
    Oncol Res; 2023; 31(6):867-875. PubMed ID: 37744269
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Transthyretin promotes the invasion of combined hepatocellular cholangiocarcinoma by tumor-associated macrophages.
    Ke K; Lin J; Huang N; Yan L; Liao R; Yang W
    Cancer Rep (Hoboken); 2023 Oct; 6(10):e1888. PubMed ID: 37688511
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Nanoparticle (NP)-mediated APOC1 silencing to inhibit MAPK/erk and NF-κB pathway and suppress breast cancer growth and metastasis.
    Liu S; Zhang F; Liang Y; Wu G; Liu R; Li X; Saw PE; Yang Z
    Sci China Life Sci; 2023 Nov; 66(11):2451-2465. PubMed ID: 37668862
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. RNF173 suppresses RAF/MEK/erk signaling to regulate invasion and metastasis via GRB2 ubiquitination in Hepatocellular Carcinoma.
    Zhou J; Tu D; Peng R; Tang Y; Deng Q; Su B; Wang S; Tang H; Jin S; Jiang G; Wang Q; Jin X; Zhang C; Cao J; Bai D
    Cell Commun Signal; 2023 Aug; 21(1):224. PubMed ID: 37626338
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mechanistic Action of Cell Cycle Arrest and Intrinsic Apoptosis via Inhibiting Akt/mTOR and Activation of p38-MAPK Signaling Pathways in Hep3B liver cancer Cells by Prunetrin-A Flavonoid with Therapeutic Potential.
    Abusaliya A; Jeong SH; Bhosale PB; Kim HH; Park MY; Kim E; Won CK; Park KI; Heo JD; Kim HW; Ahn M; Seong JK; Kim GS
    Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571343
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. (2E)-1-(2,4,6-Trimethoxyphenyl)-3-(4-chlorophenyl)prop-2-en-1-one, a Chalcone Derivative, Promotes Apoptosis by Suppressing RAS-erk and AKT/FOXO3a Pathways in Hepatocellular Carcinoma Cells.
    Zhang M; Li J; Ma R; Xi J; Xi L; Zhang B; Tian J; Bai Z
    Chem Biodivers; 2023 Jul; 20(7):e202300050. PubMed ID: 37314937
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Spleen: Report of an Aggressive Form With Molecular Characterization.
    Baber A; Legendre P; Palmic P; Lupo-Mansuet A; Burroni B; Azoulay C; Szwebel TA; Costedoat-Chalumeau N; Leroy K; Blons H; Blay JY; Boudou-Rouquette P; Terrier B
    Int J Surg Pathol; 2024 Feb; 32(1):150-154. PubMed ID: 37157817
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-erk pathway.
    Feng Z; Ke S; Wang C; Lu S; Xu Y; Yu H; Li Z; Yin B; Li X; Hua Y; Qian B; Bai M; Fu Y; Zhang Y; Wu Y; Ma Y
    Oncogene; 2023 Jun; 42(24):2017-2030. PubMed ID: 37142680
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/erk phosphorylation.
    Jiao J; Ruan L; Cheng CS; Wang F; Yang P; Chen Z
    Mol Med; 2023 Apr; 29(1):47. PubMed ID: 37016317
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.